Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1214 of 5804
-
New combo therapy aims to stop rare bone cancer from spreading
Disease control Recruiting nowThis is a prospective, single-arm, single-center clinical trial designed to evaluate the safety and efficacy of radiation combined with a BCMA/CD3 bispecific antibody (CM336) in patients with solitary bone plasmacytoma (SBP) with mild bone marrow infiltration.
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 26, 2026 14:59 UTC
-
New lupus drug YK012 enters human trials – hope for patients?
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of YK012 in participants with Moderate to Severe Systemic Lupus Erythematosus (SLE).
Phase: PHASE1, PHASE2 • Sponsor: Excyte Biopharma Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Video games as medicine? new study tests brain training for ADHD kids at home
Symptom relief Recruiting nowExplore the interventional effects of neurofeedback games on school-aged children with mild to moderate ADHD, with the aim of providing evidence-based new methods for intervening in the core symptoms of ADHD in children.
Phase: NA • Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Glow-in-the-Dark probe could save parathyroid glands during thyroid surgery
Disease control Recruiting nowThe goal of this randomized clinical trial is to learn if there are any added benefits of using near-infrared autofluorescence (NIRAF) probe-based imaging system (the PTeye) for intraoperative identification of parathyroid glands (PGs) during thyroid surgery in comparison to visu…
Phase: NA • Sponsor: Marcin Barczynski • Aim: Disease control
Last updated Jun 26, 2026 12:41 UTC
-
New sensor could spot spinal cord danger during surgery
Knowledge-focused Recruiting nowThis prospective observational study aims to evaluate the feasibility and clinical utility of near-infrared spectroscopy (NIRS) monitoring applied to paraspinal muscles as a surrogate marker of spinal cord perfusion in patients undergoing major noncardiac surgery. Spinal cord is…
Sponsor: Monaldi Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Tiny heart monitor could predict heart failure Flare-Ups
Knowledge-focused Recruiting now\[Plain language\]: Heart failure (HF) patients often experience irregular heartbeats, known as arrhythmias. Atrial fibrillation (AF) is common among HF patients and can worsen their condition, leading to strokes and higher death rates. Most of what we know about arrhythmias in H…
Phase: NA • Sponsor: Biotronik SE & Co. KG • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:56 UTC
-
Can rehab at home help stroke survivors regain arm function?
Symptom relief Recruiting nowThe purpose of this research study is to evaluate whether telerehabilitation targeting arm movement, when added to usual care, improves arm function and reduces global disability after stroke, compared to usual care alone. Patients with arm weakness due to stroke that happened i…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New immune cell combo targets hard-to-treat lymphoma in early trial
Disease control Recruiting nowOpen-label, Phase 1 Study of CD19 t-haNK as a Single Agent and in Combination With an IL-15 Superagonist (N-803) and Rituximab in Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma. Up to 20 subjects will be enrolled and randomized 1:1 to 1 of 2 cohorts, as outlined below. Th…
Phase: PHASE1 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New device helps Parkinson's patients beat freezing episodes
Symptom relief Recruiting nowThe majority of people with Parkinson's disease incur Freezing of Gait (FoG), which is not addressed adequately by medication. Cueing is a proven strategy to overcome FoG. The Cue2Walk is a device with automated detection of FoG and provision of rhythmic cues. In this study, the …
Phase: NA • Sponsor: Amsterdam UMC, location VUmc • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New drug SPY002-072 aims to tame multiple inflammatory joint diseases
Disease control OngoingThis is a multi-center, double-blind, placebo-controlled, Phase 2, proof-of-concept basket study with the goal of assessing the efficacy and safety of SPY072 compared to placebo in adults (aged ≥18 years) with rheumatic disease (RD).
Phase: PHASE2 • Sponsor: Spyre Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New combo workout shows promise for stroke recovery
Symptom relief CompletedThis randomized controlled trial aims to determine the combined effect of power training and high-intensity gait training on functional mobility and locomotion following chronic stroke.
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Could quicker brain zaps lift depression faster?
Symptom relief OngoingAn open-label, multi-center, prospective study to evaluate feasibility and efficacy of accelerated TMS for patients with Major Depressive Disorder (MDD).
Phase: NA • Sponsor: Neuronetics • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New daily pill could help kids with inherited high cholesterol
Disease control Recruiting nowThis study is designed to learn if enlicitide decanoate is safe and effective to treat children and adolescents with heterozygous familial hypercholesterolemia (HeFH) and high amounts of low-density lipoprotein cholesterol (LDL-C) in the blood. The goals of this study are to lea…
Phase: PHASE2, PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could a poop pill cure bald spots? new trial tests microbiota transplant for alopecia
Disease control Recruiting nowAlopecia Areata (AA) is among the most highly prevalent human autoimmune diseases, leading to disfiguring hair loss due to the collapse of immune privilege of the hair follicle and subsequent autoimmune attack. AA affects about 5.3 million people in the United States alone, inclu…
Phase: PHASE2 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Fewer eye injections for wet AMD? new trial tests quarterly faricimab
Disease control Recruiting nowWe aimed to investigate the success rate of a planned quarterly (every 12-16 weeks) faricimab injection schedule, following a disease inactivity achieved after initial 2-4 loading doses of faricimab, for nAMD to achieve stability without recurrence at a tertiary eye centre.
Phase: PHASE4 • Sponsor: Hospital Authority, Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Could a balloon replace stents for clogged heart arteries?
Disease control Recruiting nowAGENT DCB STANCE is a prospective, multicenter, open-label, 1:1 randomized controlled study designed to assess the safety and effectiveness of a treatment strategy with the AGENT Drug-Coated Balloon compared to standard of care percutaneous coronary intervention (PCI) treatment w…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New hope for rare blood cancer: platform trial tests multiple drugs at once
Disease control Recruiting nowThis study is a platform trial for the evaluation of new drugs or combination of drugs in relapsed or refractory peripheral T-cell lymphomas. The objective of the study is to generate exploratory data on new drugs or combination of drugs to treat refractory/relapse peripheral T-…
Phase: PHASE1, PHASE2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Common drug may keep you out of the catheter club after surgery
Prevention OngoingWhat is this study about? This study is testing whether a common medication called dexamethasone, given through a vein (IV) before surgery, can help prevent a problem called postoperative urinary retention (POUR). POUR means having trouble urinating after surgery, which can cause…
Phase: NA • Sponsor: Al-Quds University • Aim: Prevention
Last updated Jul 16, 2026 00:00 UTC
-
Personalized radiation aims to outsmart tough pancreatic tumors
Disease control Recruiting nowThe goal of this clinical trial is to learn if Adaptive Radiation Therapy (ART) is safe and effective in treating patients with locally advanced pancreatic cancer. The main questions the study aims to answer are: * Can ART improve how well radiation therapy targets the most agg…
Phase: NA • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Exercise and drug combo may fight chemo brain fog
Symptom relief Recruiting nowThis randomized, placebo-controlled trial aims to assess the feasibility, acceptability, and preliminary efficacy of memantine and the University of Carolina (UNC)'s Get Real \& Heel cancer exercise program (MEM+EX) in addressing cancer-related cognitive impairment (CRCI) and und…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC